Clinical Trials
Eli Lilly Begins Phase III Study of RA Drug to Treat COVID-19
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study.
Indianapolis-based Eli Lilly said the latest study will complement an ongoing study of the rheumatoid arthritis drug being conducted in...
News
Corning Inc to expand Valor Glass production to accelerate delivery ahead of potential COVID-19 vaccines, treatments
Corning Inc. will receive $204 million in federal funding to expand manufacturing of its Corning Valor Glass packaging in order to expand production and aid the fight against COVID-19.
The money is coming from the Biomedical Advanced Research and Development...
News
Mobidiag Ltd Receives Second Tranche of €25M Financing from European Investment Bank
Mobidiag Ltd. announces that it has received the second tranche of €10M from the €25M growth capital loan signed with the European Investment Bank Group (EIB) in May 2019. These new funds will be used to advance Mobidiag’s research...
News
Dr. Reddys Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir
Dr. Reddy's Laboratories Ltd announced that it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead)that will grant Dr. Reddy’s the right to register, manufacture and sell Gilead’s investigational drug, Remdesivir, a potential treatment for Covid-19,...
News
Biocon and Mylan get U.S. FDA approval for insulin glargine injection
Mylan N.V. and Biocon Ltd. announced that the U.S. FDA has approved the New Drug Application (NDA) for Semglee (insulin glargine injection), in vial and pre-filled pen presentations, to control high blood sugar in adults with type 2 diabetes...
News
Lonza Capsules and Health Ingredients introduces HPMC double-blinded capsules for clinical trials
A global capsule and equipment developer and manufacturer, Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical trials.
Capsugel® DBcaps® double-blinded capsules are designed to be used as an over-encapsulation tool during clinical...
News
German Federal Government invests 300 Million Euros in CureVac
The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp BioTech holding GmbH & Co. KG, announced that the Federal Republic of Germany will invest...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.